Insights

Fifteen+ years of
Healthcare thinking.

Several hundred perspectives on the questions facing payers, providers, biopharma, medtech, and digital health — plus our running read on the clinical literature. Start with our sharpest work, or filter to your world.

Recon speaks with AJMC on emerging outcomes data for high touch primary care models in commercial populations

  • In the News
More frequent routine primary care visits for certain higher-risk comm…

Read more

AJMC: More frequent visits to primary care can save net $30-40 PMPM for top 20% highest risk commercial members

  • Payers , 
  • Providers
A new AJMC study from consulting firm Recon Strategy is the first to s…

Read more

Recon analysis in AJMC demonstrates, for the first time for commercially covered patients, the value of risk-stratifying primary care visit frequency

  • In the News
More frequent routine primary care visits for certain higher-risk comm…

Read more

Walmart Health didn’t test the opportunity in rural underserved markets

  • Providers
What lessons can be drawn from Walmart’s precipitous shut down of its …

Read more

What’s so special about One Medical in the eyes of Amazon? A few quick thoughts

  • Providers , 
  • Digital , 
There isn’t a bricks-and-mortar primary care acquisition out there tha…

Read more

Iora Agonistes: High-touch primary care in Medicare Advantage is no sure bet after all

  • Providers
Iora Health was one of the original primary care transformers offering…

Read more

NEJM Highlights October 2015: what to do, how to do it, and to whom

  • NEJM
What are annual physicals for? Annual physicals are costly (~$10 billi…

Read more

NEJM Highlights July 2015: a first in class drug for cancer, Sovaldi cures renal failure too (sometimes), convenient primary care

  • NEJM
Palbociclib – first to target cyclin dependent kinases – breast cancer…

Read more